Belzutifan (PT2977)
Belzutifan (PT2977) (S8886-GRP)
Products
Description
Belzutifan (PT2977), an orally active and selective HIF-2α inhibitor, increases potency and improves pharmacokinetic profile, providing a potential treatment for clear cell renal cell carcinoma (ccRCC).
Specifications
| Manufacturer | Selleck Chemicals LLC |
|---|---|
| Manufacturer Cat# | S8886 |
| Target | HIF |